Biology:LILRB2

From HandWiki
Short description: Protein-coding gene in the species Homo sapiens


A representation of the 3D structure of the protein myoglobin showing turquoise α-helices.
Generic protein structure example

Leukocyte immunoglobulin-like receptor subfamily B member 2 is a protein that in humans is encoded by the LILRB2 gene.[1][2][3]

This gene is a member of the leukocyte immunoglobulin-like receptor (LIR) family, which is found in a gene cluster at chromosomal region 19q13.4. The encoded protein belongs to the subfamily B class of LIR receptors which contain two or four extracellular immunoglobulin domains, a transmembrane domain, and two to four cytoplasmic immunoreceptor tyrosine-based inhibitory motifs (ITIMs). The receptor is expressed on immune cells where it binds to MHC class I molecules on antigen-presenting cells and transduces a negative signal that inhibits stimulation of an immune response. It is thought to control inflammatory responses and cytotoxicity to help focus the immune response and limit autoreactivity. Multiple transcript variants encoding different isoforms have been found for this gene.[3]

LILBR2 plays a critical role in the inhibition of axonal regeneration and functional recovery after brain injury.[4] However, recent studies demonstrate that LILRB2 is a β-Amyloid receptor and may contribute to synaptic loss and cognitive impairment in Alzheimer's disease.[5][6]

Interactions

LILRB2 has been shown to interact with PTPN6.[7][8]

See also

References

  1. "A novel inhibitory receptor (ILT3) expressed on monocytes, macrophages, and dendritic cells involved in antigen processing". The Journal of Experimental Medicine 185 (10): 1743–1751. May 1997. doi:10.1084/jem.185.10.1743. PMID 9151699. 
  2. "Cloning of novel immunoglobulin superfamily receptors expressed on human myeloid and lymphoid cells: structural evidence for new stimulatory and inhibitory pathways". European Journal of Immunology 27 (3): 660–665. March 1997. doi:10.1002/eji.1830270313. PMID 9079806. 
  3. 3.0 3.1 "Entrez Gene: LILRB2 leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 2". https://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=10288. 
  4. "Inhibition of PirB Activity by TAT-PEP Improves Mouse Motor Ability and Cognitive Behavior". Frontiers in Aging Neuroscience 9: 199. 2017. doi:10.3389/fnagi.2017.00199. PMID 28676756. 
  5. "Identification of novel Aβ-LilrB2 inhibitors as potential therapeutic agents for Alzheimer's disease". Molecular and Cellular Neurosciences 114: 103630. July 2021. doi:10.1016/j.mcn.2021.103630. PMID 34029694. 
  6. "Human LilrB2 is a β-amyloid receptor and its murine homolog PirB regulates synaptic plasticity in an Alzheimer's model". Science 341 (6152): 1399–1404. September 2013. doi:10.1126/science.1242077. PMID 24052308. Bibcode2013Sci...341.1399K. 
  7. "The MHC class I binding proteins LIR-1 and LIR-2 inhibit Fc receptor-mediated signaling in monocytes". European Journal of Immunology 28 (11): 3423–3434. November 1998. doi:10.1002/(SICI)1521-4141(199811)28:11<3423::AID-IMMU3423>3.0.CO;2-2. PMID 9842885. 
  8. "Human myelomonocytic cells express an inhibitory receptor for classical and nonclassical MHC class I molecules". Journal of Immunology 160 (7): 3096–3100. April 1998. doi:10.4049/jimmunol.160.7.3096. PMID 9531263. 

Further reading

External links

This article incorporates text from the United States National Library of Medicine, which is in the public domain.